(Q47776137)

English

Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice

scientific article published on 28 May 2009

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

Katia Sparnacci

9

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

Riccardo Gavioli

11

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

object named as

Luisa Tondelli

7

0 references

object named as

Eva Reali

10

0 references

Antonella Caputo

object named as

Antonella Caputo

13

0 references

object named as

Barbara Ensoli

12

0 references

Egidio Brocca-Cofano

3

object named as

Egidio Brocca-Cofano

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

Arianna Castaldello

2

object named as

Arianna Castaldello

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

Rita De Michele

4

object named as

Rita De Michele

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

1

object named as

Rebecca Voltan

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

5

object named as

Chiara Triulzi

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

author name string

Giuseppe Altavilla

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

language of work or name

0 references

publication date

28 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

27

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

33

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

4498-4507

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

DNA vaccines for biodefence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

DNA vaccines: progress and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

DNA vaccines: a key for inducing long-term cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Microparticles for the delivery of DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Vaccinology at the beginning of the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Intelligent polymers as nonviral vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Polyethylene glycol-conjugated copolymers for plasmid DNA delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

A new gene delivery system based on controlled release technology

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Role of endosomes in gene transfection mediated by photochemical internalisation (PCI).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Complex associates of plasmid DNA and a novel class of block copolymers with PEG and cationic segments as new vectors for gene delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Micellar-type complexes of tailor-made synthetic block copolymers containing the HIV-1 tat DNA for vaccine application

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Immunization with low doses of HIV-1 tat DNA delivered by novel cationic block copolymers induces CTL responses against Tat.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Nucleic acid vaccination with HIV regulatory genes: a combination of HIV-1 genes in separate plasmids induces strong immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Candidate HIV-1 Tat vaccine development: from basic science to clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

The therapeutic phase I trial of the recombinant native HIV-1 Tat protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

HIV-1 tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Introduction: rational vaccine strategies against AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Criteria for selection of HIV vaccine candidates—general principles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Rational vaccine strategies against AIDS: background and rationale

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 ΔV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Recent advances in the development of HIV-1 Tat-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

CD4+ T cells are required for the maintenance, not programming, of memory CD8+ T cells after acute infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Immunobiology of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Improved vaccine protection from simian AIDS by the addition of nonstructural simian immunodeficiency virus genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Human immunodeficiency virus type 1 Rev- and Tat-specific cytotoxic T lymphocyte frequencies inversely correlate with rapid progression to AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Antibody to HIV-1 Tat protein inhibits the replication of virus in culture.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

HIV-1 Tat raises an adjuvant-free humoral immune response controlled by its core region and its ability to form cysteine-mediated oligomers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Protein transduction: unrestricted delivery into all cells?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Human immunodeficiency virus (HIV) Tat-reactive antibodies present in normal HIV-negative sera and depleted in HIV-positive sera. Identification of the epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

HIV vaccine development: lessons from the past and promise for the future

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

HIV vaccines 1983-2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.031

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.05.031

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/19450649

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47776137&oldid=2170523203"